Related Experiment Video
Updated: Jan 23, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
An Update on Pediatric Cardiomyopathy
Swati Choudhry1, Kriti Puri2, Susan W Denfield2
1Department of Pediatrics, Section of Pediatric Cardiology, Texas Children's Hospital, Baylor College of Medicine, 6651 Main St, Houston, TX, 77030, USA. sxchoudh@texaschildrens.org.
Insights
Pediatric cardiomyopathies, often genetic, significantly impact children
Area of Science:
- Cardiology
- Pediatric Medicine
- Genetics
Background:
- Pediatric cardiomyopathies are rare but serious heart muscle diseases affecting children.
- These progressive conditions are frequently caused by genetic mutations leading to myocyte abnormalities.
- Dilated cardiomyopathy (DCM) is most common (50-60%), followed by hypertrophic cardiomyopathy (HCM) (40%).
Purpose of the Study:
- To review clinical characteristics and outcomes of primary pediatric cardiomyopathies.
- To summarize data on dilated (DCM), hypertrophic (HCM), restrictive (RCM), and left ventricular non-compaction (LVNC) cardiomyopathies.
- To briefly discuss arrhythmogenic cardiomyopathy (ACM), predominantly arrhythmogenic right ventricular cardiomyopathy (ARVC).
Main Methods:
- Literature review of clinical characteristics and updated outcomes.
- Synthesis of data on prevalence, etiology, and prognosis.
- Discussion of current treatment strategies and challenges in pediatric populations.
Main Results:
- Estimated annual incidence of pediatric cardiomyopathies is 1.1-1.5 per 100,000.
- Five-year transplant-free survival rates vary: DCM (50%), HCM (90%), RCM (30%), LVNC (60%).
- Genetic mutations are a dominant factor; current treatments alleviate symptoms but don't prevent sudden death.
Conclusions:
- Pediatric cardiomyopathies are a significant cause of childhood morbidity and mortality.
- Dilated and hypertrophic forms are most prevalent, with genetic factors playing a key role.
- Treatment guidelines are largely based on adult data, with unclear indications for ICD placement in children.
Purpose Of Review:
This review summarizes the clinical characteristics and updated outcomes of primary pediatric cardiomyopathies including dilated (DCM), hypertrophic (HCM), and restrictive cardiomyopathy (RCM), and briefly discusses left ventricular non-compaction (LVNC) and arrhythmogenic cardiomyopathy (ACM), primarily arrythmogenic right ventricular cardiomyopathy (ARVC).
Recent Findings:
Pediatric cardiomyopathies are diseases of the heart muscle with an estimated annual incidence of 1.1-1.5 cases per 100,000. They are progressive in nature and are frequently caused by a genetic mutation causing a structural abnormality in the myocyte. Dilated cardiomyopathy, characterized by left ventricular dilation and systolic dysfunction with normal left ventricular wall thickness, accounts for about 50-60% of all pediatric cardiomyopathy cases. This is followed by hypertrophic cardiomyopathy accounting for about 40%, characterized by abnormally thickened myocardium in the absence of another cause of hypertrophy with non-dilated left ventricle. Left ventricular non-compaction and restrictive cardiomyopathy each account for about 5% of the cases. Genetic mutations play a dominant role in the development of pediatric cardiomyopathies. While treatment for congestive heart failure and arrhythmias alleviates symptoms, it has not been shown to reduce the risk of sudden death. The 5-year transplant-free survival of DCM, HCM, RCM, and LVNC are 50%, 90%, 30%, and 60% respectively. Pediatric cardiomyopathies while not common they are a significant cause of morbidity and mortality in afflicted children. Dilated forms are the most common followed by hypertrophic, left ventricular non-compaction, and restrictive cardiomyopathies. Arrhythmogenic cardiomyopathies tend to be diagnosed later in the teenage years. Treatment typically follows adult recommendations for which there is significantly more data on treatment benefits, although the indications for ICD placement in children remain even less clear, other than for secondary prevention.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy VI: Nursing Management
Cardiomyopathy V: Interprofessional Care

